PL354413A1 - Kompozycja przeznaczona do zapobiegania zaburzeniom krążenia i/lub leczenia ich, zawierająca pochodne L-karnityny i wyciągi Ginkgo biloba - Google Patents

Kompozycja przeznaczona do zapobiegania zaburzeniom krążenia i/lub leczenia ich, zawierająca pochodne L-karnityny i wyciągi Ginkgo biloba

Info

Publication number
PL354413A1
PL354413A1 PL00354413A PL35441300A PL354413A1 PL 354413 A1 PL354413 A1 PL 354413A1 PL 00354413 A PL00354413 A PL 00354413A PL 35441300 A PL35441300 A PL 35441300A PL 354413 A1 PL354413 A1 PL 354413A1
Authority
PL
Poland
Prior art keywords
ofginkgo
biloba
carnitine
extracts
prevention
Prior art date
Application number
PL00354413A
Other languages
English (en)
Other versions
PL199996B1 (pl
Inventor
Claudio Cavazza
Original Assignee
Sigma-Tau Healthscience S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Healthscience S.P.A. filed Critical Sigma-Tau Healthscience S.P.A.
Publication of PL354413A1 publication Critical patent/PL354413A1/pl
Publication of PL199996B1 publication Critical patent/PL199996B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL354413A 1999-10-08 2000-10-02 Kompozycja połączenia zawierająca L-karnitynę i wyciąg Ginkgo biloba i zastosowanie kompozycji PL199996B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999RM000618A IT1306722B1 (it) 1999-10-08 1999-10-08 Composizione per la prevenzione e/o il trattamento di disfunzionicircolatorie, comprendente derivati della l-carnitina ed estratti di
PCT/IT2000/000391 WO2001026666A2 (en) 1999-10-08 2000-10-02 Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba

Publications (2)

Publication Number Publication Date
PL354413A1 true PL354413A1 (pl) 2004-01-12
PL199996B1 PL199996B1 (pl) 2008-11-28

Family

ID=11406992

Family Applications (1)

Application Number Title Priority Date Filing Date
PL354413A PL199996B1 (pl) 1999-10-08 2000-10-02 Kompozycja połączenia zawierająca L-karnitynę i wyciąg Ginkgo biloba i zastosowanie kompozycji

Country Status (21)

Country Link
US (1) US6641849B1 (pl)
EP (1) EP1218022B1 (pl)
AR (1) AR025790A1 (pl)
AT (1) ATE237341T1 (pl)
AU (1) AU780643B2 (pl)
CA (1) CA2386770C (pl)
CZ (1) CZ20021062A3 (pl)
DE (1) DE60002226T2 (pl)
DK (1) DK1218022T3 (pl)
ES (1) ES2195939T3 (pl)
HU (1) HU227042B1 (pl)
IL (1) IL148963A0 (pl)
IT (1) IT1306722B1 (pl)
MX (1) MXPA02003501A (pl)
NO (1) NO20021640L (pl)
PL (1) PL199996B1 (pl)
PT (1) PT1218022E (pl)
SK (1) SK4052002A3 (pl)
TN (1) TNSN00186A1 (pl)
TR (1) TR200200948T2 (pl)
WO (1) WO2001026666A2 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1316998B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori.
IT1317035B1 (it) * 2000-05-30 2003-05-26 Sigma Tau Healthscience Spa Integratore ad attivita' antiossidante comprendente unaalcanoilcarnitina ed una associazione di polifenoli estratti dal
PL363426A1 (pl) * 2001-03-09 2004-11-15 Societe Des Produits Nestle S.A. Kompozycja do łagodzenia deficytów fizjologicznych związanych z wiekiem sprzyjająca wydłużeniu życia
ITRM20010708A1 (it) * 2001-12-04 2003-06-04 Sigma Tau Ind Farmaceuti Uso di una alcanoil l-carnitina per il trattamento della disfunzione erettile.
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
EP1750808B1 (en) 2004-05-18 2011-02-09 Bright Future Pharmaceutical Laboratories Limited Myricitrin compounds for treating sleeping disorders
GB0411166D0 (en) * 2004-05-19 2004-06-23 Bionovate Ltd Treatment for asthma and arthritis
ITRM20040561A1 (it) * 2004-11-11 2005-02-11 Sigma Tau Ind Farmaceuti Uso della acetil l-carnitina in combinazione con propionil l-carnitina e sildenafil per il trattamento della disfunzione erettile.
AR070816A1 (es) * 2008-03-14 2010-05-05 Otsuka Pharma Co Ltd Farmaco de combinacion para tratar trastornos vasculares
US20110217252A1 (en) * 2008-11-11 2011-09-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Compound useful for treating cellulite
US20110015154A1 (en) * 2009-07-20 2011-01-20 Kellermann Gottfried H Supporting acetylcholine function
US20110098265A1 (en) * 2009-10-28 2011-04-28 Neuroscience, Inc. Methods for reducing cravings and impulses associated with addictive and compulsive behaviors
CZ308282B6 (cs) * 2010-08-05 2020-04-15 Výzkumný ústav živočišné výroby, v. v. i. Krmný doplněk pro zvýšení libida kanců
CN102783568B (zh) * 2012-08-29 2014-05-14 山东中医药大学 一种饲料添加剂
EP2952209B1 (en) * 2014-06-04 2018-03-28 Alfasigma S.p.A. Homogeneous formulations comprising omega-3 polyunsaturated fatty acids (n-3 PUFA) and resveratrol for oral administration

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254314B (it) * 1992-03-27 1995-09-14 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
DE9318632U1 (de) * 1993-12-06 1995-04-06 Emsa-Werke Wulf GmbH & Co, 48282 Emsdetten Vorrichtung zum Aufnehmen von Folienrollen
US6221356B1 (en) * 1996-12-13 2001-04-24 Viva America Marketing, Inc. Method of preparation of biologically active Ginkgo biloba product
JP2001511153A (ja) * 1997-02-04 2001-08-07 ブイ． コスバブ，ジョン 血管変性性疾患の予防および処置のための組成物および方法
IT1294227B1 (it) * 1997-08-01 1999-03-24 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l-carnitina e alcoli alifatici a lunga catena utile per la prevenzione
IT1306130B1 (it) * 1999-04-16 2001-05-30 Sigma Tau Healthscience Spa Composizione comprendente una carnitina e glutatione, atta adaumentare l'assorbimento del glutatione sinergizzandone gli effetti.

Also Published As

Publication number Publication date
ITRM990618A1 (it) 2001-04-08
SK4052002A3 (en) 2002-09-10
AU7945600A (en) 2001-04-23
DE60002226D1 (de) 2003-05-22
US6641849B1 (en) 2003-11-04
IT1306722B1 (it) 2001-10-02
HU227042B1 (en) 2010-05-28
TNSN00186A1 (fr) 2005-11-10
ES2195939T3 (es) 2003-12-16
HUP0203449A3 (en) 2005-04-28
DK1218022T3 (da) 2003-08-11
WO2001026666A3 (en) 2001-09-13
WO2001026666A2 (en) 2001-04-19
CA2386770A1 (en) 2001-04-19
PT1218022E (pt) 2003-09-30
CZ20021062A3 (cs) 2002-08-14
AR025790A1 (es) 2002-12-11
HUP0203449A2 (hu) 2003-02-28
EP1218022A2 (en) 2002-07-03
ITRM990618A0 (it) 1999-10-08
NO20021640D0 (no) 2002-04-05
ATE237341T1 (de) 2003-05-15
NO20021640L (no) 2002-05-29
EP1218022B1 (en) 2003-04-16
IL148963A0 (en) 2002-11-10
PL199996B1 (pl) 2008-11-28
AU780643B2 (en) 2005-04-07
CA2386770C (en) 2009-09-08
TR200200948T2 (tr) 2002-10-21
DE60002226T2 (de) 2004-03-04
MXPA02003501A (es) 2002-09-02

Similar Documents

Publication Publication Date Title
HUP0201409A2 (en) Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
HUP0103856A3 (en) Pharmaceutical composition for the treatment of acute disorders
PT1231887E (pt) Método e composição para o tratamento de cicatrizes
IL147217A0 (en) New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain
IL127943A (en) Pharmaceutical and cosmetic compositions for the treatment of skin disorders
AU7722600A (en) Compositions and methods for the diagnosis and treatment of immune disorders
HU9803018D0 (en) Methods and compositions for the treatment and prevention of tumors, tumor-veloted disorders and cachexia
PL354413A1 (pl) Kompozycja przeznaczona do zapobiegania zaburzeniom krążenia i/lub leczenia ich, zawierająca pochodne L-karnityny i wyciągi Ginkgo biloba
HUP0104688A3 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
AU5309600A (en) Compositions and methods for the treatment and diagnosis of immune disorders
AU1509999A (en) Herbal drug composition for the prevention and treatment of dementia
AU2001256855A1 (en) Preparation for the prevention and treatment of ocular disorders
AU6330999A (en) Rhodanine derivatives for the treatment and prevention of metabolic bone disorders
AU7601400A (en) Treatment and prevention of hepatic disorders
HUP0203379A3 (en) Composition for the prevention and/or treatment of disorders due to abnormal lipid metabolism, comprising propionyl l-carnitine and chitosan
HU0500865D0 (en) Use of teophyllin derivatives for the preparation of pharmaceutical compositions for the prevention and treatment of shock
IL137940A0 (en) Treatment or prevention of coccidiosis
HUP0204467A3 (en) Composition for the prevention and/or treatment of vascular diseases, comprising propionyl l-carnitine and coenzyme q10
IL143903A0 (en) Use of phanquinone for the treatment or prevention of memory impairment
AU5416500A (en) Pharmaceutical composition for the treatment of calcification
GC0000176A (en) Pharmaceutical combination preparations for the treatment of cardiac disorders
AUPQ212899A0 (en) Composition & method for the prevention & treatment of skin disorders
EP1194162A4 (en) COMPOSITIONS AND METHODS OF PREVENTING, TREATING AND DETECTING TUBERHULOSIS AND OTHER DISEASES
IL137190A0 (en) Pharmaceutical compositions for the treatment of dyskinesias
IL122883A0 (en) Pharmaceutical compositions for the treatment of dyskinesias